Baldness: Comprehensive aspects and its reassuring remedies

Arghya Bhattacharya; Pronoy Mukherjee; Soumik Bhattacharjee; Dattatreya Mukherjee; Chanchal Koley; Bikram Dhara; Tanmay Sanyal

doi:10.52756/ijerr.2023.v32.007

Arghya Bhattacharya Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology and Allied Health Science, Uluberia, Howrah, West Bengal-711316, India
Pronoy Mukherjee Department of Zoology, Rishi Bankim Chandra College, Naihati, West Bengal, India https://orcid.org/0000-0002-4901-0141
Soumik Bhattacharjee Department of Pharmacology, Gupta College of Technological Sciences, Asansol, West Bengal, India
Dattatreya Mukherjee Raiganj Government Medical College and Hospital, India https://orcid.org/0000-0001-7566-3843
Chanchal Koley Department of Pharmacology, Bengal College of Pharmaceutical Technology, Dubrajpur, West Bengal, India
Bikram Dhara Department of Microbiology, St. Xavier’s College, Kolkata, India
Tanmay Sanyal Department of Zoology, Krishnagar Government College, Krishnagar, West Bengal, India https://orcid.org/0000-0002-0046-1080

DOI: https://doi.org/10.52756/ijerr.2023.v32.007

Keywords: Baldness, Androgenetic baldness, DHT Blocker, Minoxidil, Nourishing support, Herbal remedies

Abstract

The medical term for baldness is alopecia. It refers to the condition where hair is lost from one or more areas of the body, commonly from the scalp. Balding can result from various factors, including genetic predisposition, environmental triggers, exposure to chemicals, medications, nutritional deficiencies, excessive stress, or prolonged illness. Depending on the pattern of hair loss and its underlying cause, alopecia is categorized into several types. Among these, androgenetic alopecia and alopecia areata are of primary concern. Presently, there are numerous synthetic treatments available for managing alopecia (both areata and androgenetic alopecia), including minoxidil, corticosteroids, zinc, dithranol, systemic cortisone, tretinoin, irritants, immunosuppressants, azelaic acid, and finasteride. However, these treatments often fail to provide satisfactory and long-lasting results for individuals with alopecia. Moreover, these synthetic products are associated with adverse effects, such as itching, redness, dermatitis, flaking, and irritation. Natural remedies have been explored to address the challenge of hair loss. A variety of herbs have demonstrated efficacy in managing alopecia. These natural remedies operate through mechanisms such as nutritional support, 5-α-reductase and DHT (dihydrotestosterone) inhibition, aromatherapy, and improved scalp blood circulation. Utilizing these natural treatments offers several advantages, including patient adherence, minimal side effects, easy accessibility, affordability, and diverse modes of therapeutic action for hair loss management. In this review, we highlighted the causes of alopecia and its promising, cost-effective treatments, which might significantly alter the lives of those impacted by baldness by providing them with a road to greater self-assurance, well-being, and quality of life.

References

Bienenfeld, A., Azarchi, S., Sicco, K. L., Marchbein, S., Shapiro, J., & Nagler, A. R. (2019). Androgens in women: Androgen-mediated skin disease and patient evaluation. Journal of the American Academy of Dermatology, 80(6), 1497-1506. https://doi.org/10.1016/j.jaad.2018.08.062.

Blume‐Peytavi, U., Kunte, C., Krisp, A., Bartels, N. G., Ellwanger, U., & Hoffmann, R. (2007). Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 5(5), 391-395. https://doi.org/10.1111/j.1610-0387.2007.06295.x

Botchkarev, V. A., Komarova, E. A., Siebenhaar, F., Botchkareva, N. V., Komarov, P. G., Maurer, M., Gilchrest, B.A., & Gudkov, A. V. (2000). p53 is essential for chemotherapy-induced hair loss. Cancer Research, 60(18), 5002-5006.

Brotzu, G., Fadda, A. M., Manca, M. L., Manca, T., Marongiu, F., Campisi, M., & Consolaro, F. (2019). A liposome‐based formulation containing equol, dihomo‐γ‐linolenic acid and propionyl‐l‐carnitine to prevent and treat hair loss: a prospective investigation. Dermatologic Therapy, 32(1), e12778. https://doi.org/10.1111/dth.12778.

Carmina, E., & Lobo, R. A. (2003). Treatment of hyperandrogenic alopecia in women. Fertility and Sterility, 79(1), 91-95. https://doi.org/10.1016/S0015-0282(02)04551-X

Chadwick, J., & Mann, W. N. (1950). The medical works of Hippocrates. Oxford Blackwell Scientific Publications.

Chizick, S., & Delorscio, R. (1999). U.S. Patent No. 5,972,345. Washington, DC: U.S. Patent and Trademark Office.

Cotsarelis, G., & Millar, S. E. (2001). Towards a molecular understanding of hair loss and its treatment. Trends in Molecular Medicine, 7(7), 293-301. https://doi.org/10.1016/S1471-4914(01)02027-5.

Davis, S. T., Benson, B. G., Bramson, H. N., Chapman, D. E., Dickerson, S. H., Dold, K. M., Eberwein, D. J., Edelstein, M., Frye, S.V., Gampe, R.T. Jr., Griffin, R.J., Harris, P. A., Hassell, A.M., Holmes, W.D., Hunter, R.N., Knick, V.B., Lackey, K., Lovejoy, B., Luzzio, M.J., Murray, D., Parker, P., Rocque, W.J., Shewchuk, L., Veal, J.M., Walker, D.H., & Kuyper, L. F. (2001). Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science, 291(5501), 134-137. http:// doi.org/10.1126/science.291.5501.134.

Dhurat, R., Sharma, A., Rudnicka, L., Kroumpouzos, G., Kassir, M., Galadari, H., Wollina, U., Lotti, T., Golubovic, M., Binic, I., Grabbe, S., & Goldust, M. (2020). 5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety. Dermatologic Therapy, 33(3), e13379. https://doi.org/10.1111/dth.13379.

Ellis, R. A. (1958). Ageing of the human male scalp. The biology of hair growth, Eds., Montagna, W. and Ellis, R. A. Academic Press, New York, pp. 469-485.

Esfandiari, A., & Kelly, A. P. (2005). The effects of tea polyphenolic compounds on hair loss among rodents. Journal of the National Medical Association, 97(8), 1165.

Fortes, C., Mastroeni, S., Mannooranparampil, T., Abeni, D., & Panebianco, A. (2018). Mediterranean diet: Fresh herbs and fresh vegetables decrease the risk of Androgenetic Alopecia in males. Archives of Dermatological Research, 310(1), 71–76. https://doi.org/10.1007/s00403-017-1799-z.

Garza, L. A., Liu, Y., Yang, Z., Alagesan, B., Lawson, J. A., Norberg, S. M., Loy, D.E., Zhao, T., Blatt, H.B., Stanton, D.C., Carrasco, L., Ahluwalia, G., Fischer, S.M., FitzGerald, G.A., & Cotsarelis, G. (2012). Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Science Translational Medicine, 4(126), 126ra34-126ra34. https://doi.org/10.1126/scitranslmed.3003122.

Gc, D. B., Bhandari, J., Gautam, D., Jan, H. A., Abbasi, A. M., Bussmann, R. W., & Paniagua-Zambrana, N. Y. (2021). Juglans regia l. Juglandaceae. Springer International Publishing. In R. M. Kunwar, H. Sher, & R. W. Bussmann (Eds.), Ethnobotany of the Himalayas, pp. 1123–1139. https://doi.org/10.1007/978-3-030-57408-6_132.

Gilhar, A., Ullmann, Y., Berkutzki, T., Assy, B., & Kalish, R. S. (1998). Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. The Journal of Clinical Investigation, 101(1), 62-67. http:// doi.org/ 10.1172/JCI551.

Girijala, R. L., Riahi, R. R., & Cohen, P. R. (2018). Platelet-rich plasma for androgenic alopecia treatment: a comprehensive review. Dermatology Online Journal, 24(7). https://doi.org/10.5070/D3247040910.

Greenish, H. G. (1920). A text book of materia medica, being an account of the more important crude drugs of vegetable and animal origin, designed for students of pharmacy and medicine.

Hajheydari, Z., Jamshidi, M., Akbari, J., & Mohammadpour, R. (2007). Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: a double-blind randomized controlled study. Indian Journal of Dermatology, Venereology and Leprology, 73, 29. https://doi.org/ 10.4103/0378-6323.30648.

Hajimehdipoor, H., Nikmanesh, N., & Mohammadi-Motamed, M. (2019). Amla oil, a pharmaceutical product based on traditional knowledge for alopecia treatment. Res. J. Pharmacogn., 6(1), 57-61.

Hamilton, J. B. (1942). Male hormone stimulation is prerequisite and an incitant in common baldness. American Journal of Anatomy, 71(3), 451–480. https://doi.org/10.1002/aja.1000710306.

Hamilton, J. B. (1951). Patterned loss of hair in man: types and incidence. Annals of the New York Academy of Sciences, 53(3), 708-728. https://doi.org/10.1111/j.1749-6632.1951.tb31971.x.

Harada, N., Okajima, K., Arai, M., Kurihara, H., & Nakagata, N. (2007). Administration of capsaicin and isoflavone promotes hair growth by increasing insulin-like growth factor-I production in mice and in humans with alopecia. Growth Hormone & IGF Research, 17(5), 408-415. https://doi.org/10.1016/j.ghir.2007.04.009.

Headington, J. T. (1993). Telogen effluvium: new concepts and review. Archives of dermatology, 129(3), 356-363. http:// doi.org/10.1001/archderm.1993.01680240096017.

Heilmann, S., Brockschmidt, F. F., Hillmer, A. M., Hanneken, S., Eigelshoven, S., Ludwig, K. U., Herold, C., Mangold, E., Becker, T., Kruse, R., Knapp, M., & Nöthen, M. M. (2013). Evidence for a polygenic contribution to androgenetic alopecia. British Journal of Dermatology, 169(4), 927-930. https://doi.org/10.1111/bjd.12443.

Heilmann, S., Kiefer, A. K., Fricker, N., Drichel, D., Hillmer, A. M., Herold, C., Tung, J.Y., Eriksson, N., Redler, S., Betz, R.C., Li, R., Kárason, A., Nyholt, D.R., Song, K., Vermeulen, S.H., Kanoni, S., Dedoussis, G., Martin, N.G., Kiemeney, L.A., Mooser, V., Stefansson, K., Richards, J.B., Becker, T., Brockschmidt, F.F., Hinds, D.A., & Nöthen, M. M. (2013). Androgenetic alopecia: identification of four genetic risk loci and evidence for the contribution of WNT signaling to its etiology. Journal of Investigative Dermatology, 133(6), 1489-1496. https://doi.org/10.1038/jid.2013.43.

Hillmer, A. M., Flaquer, A., Hanneken, S., Eigelshoven, S., Kortüm, A. K., Brockschmidt, F. F., ... & Nöthen, M. M. (2008). Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. The American Journal of Human Genetics, 82(3), 737-743. https://doi.org/10.1016/j.ajhg.2007.11.014.

Hillmer, A. M., Hanneken, S., Ritzmann, S., Becker, T., Freudenberg, J., Brockschmidt, F. F., ... & Nöthen, M. M. (2005). Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. The American Journal of Human Genetics, 77(1), 140-148. https://doi.org/10.1086/431425

Hirshburg, J. M., Kelsey, P. A., Therrien, C. A., Gavino, A. C., & Reichenberg, J. S. (2016). Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review. The Journal of Clinical and Aesthetic Dermatology, 9(7), 56.

Inui, S., & Itami, S. (2007). Reversal of androgenetic alopecia by topical ketoconzole: relevance of anti-androgenic activity. Journal of Dermatological Science, 45(1), 66-68. https://doi.org/10.1016/j.jdermsci.2006.08.011.

Jain, P. K., & Das, D. (2016). The wonder of herbs to treat-Alopecia. Innov. J. Med. Sci., 4(5), 1-6.

Jones, M. C. (2018). Treatment options for androgenetic alopecia. US Pharm, 43(8), 12-16.

Kaufman, K. D. (2002). Androgens and alopecia. Molecular and Cellular Endocrinology, 198(1–2), 89–95. https://doi.org/10.1016/S0303-7207(02)00372-6.

Liang, B., Yang, C., Zuo, X., Li, Y., Ding, Y., Sheng, Y., ... & Zhang, X. (2013). Genetic variants at 20p11 confer risk to androgenetic alopecia in the Chinese Han population. PLoS One, 8(8), e71771. https://doi.org/10.1371/journal.pone.0071771.

Liao, S. S., & Hiipakka, R. A. (1995). Selective-Inhibition of steroid 5 α-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochemical and Biophysical Research Communications, 214(3), 833-838. https://doi.org/10.1006/bbrc.1995.2362.

Liu, S., & Yamauchi, H. (2008). Different patterns of 5α-reductase expression, cellular distribution, and testosterone metabolism in human follicular dermal papilla cells. Biochemical and Biophysical Research Communications, 368(4), 858-864. https://doi.org/10.1016/j.bbrc.2008.01.130.

Liu, W. K., Xu, S. X., & Che, C. T. (2000). Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sciences, 67(11), 1297-1306.

Marks, L. S., Hess, D. L., Dorey, F. J., Macairan, M. L., Santos, P. B. C., & Tyler, V. E. (2001). Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens. Urology, 57(5), 999-1005. https://doi.org/10.1016/S0090-4295(00)01052-9.

Martinez-Jacobo, L., Villarreal-Villarreal, C. D., Ortiz-López, R., Ocampo-Candiani, J., & Rojas-Martínez, A. (2018). Genetic and molecular aspects of androgenetic alopecia. Indian journal of dermatology, venereology and leprology, 84, 263. https://doi.org/10.4103/ijdvl.IJDVL_262_17.

Mesinkovska, N. A., & Bergfeld, W. F. (2013). Hair: What is New in Diagnosis and Management?: Female Pattern Hair Loss Update: Diagnosis and Treatment. Dermatologic clinics, 31(1), 119-127. https://doi.org/10.1016/j.det.2012.08.005.

Montagna, W., & Ellis, R. A. (2014). The biology of hair growth. Elsevier Science.

Mulder, W. M. C., & Meinardi, M. M. H. M. (2003). Dermatological drugs and topical agents. In Side Effects of Drugs Annual (Vol. 26, pp. 168-179). Elsevier. https://doi.org/10.1016/S0378-6080(03)80021-1.

Peereboom-Wynia, J. D. R., Van der Willigen, A. H., Stolz, E., & Van Joost, T. (1989). The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females. Trends in Human Hair Growth and Alopecia Research, 207-213.

Peiffer, V. (2013). Regrowing Hair Naturally: Effective Remedies and Natural Treatments for Men and Women with Alopecia Areata, Alopecia Androgenetica, Telogen Effluvium and Other Hair Loss Problems. Singing Dragon.

Perez, B. H. (2004). Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men. Medical hypotheses, 62(1), 112-115. https://doi.org/10.1016/S0306-9877(03)00264-0.

Prager, N., Bickett, K., French, N., & Marcovici, G. (2002). A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-α-reductase in the treatment of androgenetic alopecia. Journal of Alternative & Complementary Medicine, 8(2), 143-152. https://doi.org/10.1089/acm.2002.8.143.

Prodi, D. A., Pirastu, N., Maninchedda, G., Sassu, A., Picciau, A., Palmas, M. A., Mossa, A., Persico, I., Adamo, M., Angius, A., & Pirastu, M. (2008). Eda2r is associated with androgenetic alopecia. Journal of Investigative Dermatology, 128(9), 2268–2270. https://doi.org/10.1038/jid.2008.60.

Rambwawasvika, H., Dzomba, P., & Gwatidzo, L. (2021). Alopecia types, current and future treatment. J Dermatol Cosmetol, 5(4), 93-99.

Rathnayake, D., & Sinclair, R. (2010). Male androgenetic alopecia. Expert Opinion on Pharmacotherapy, 11(8), 1295–1304. https://doi.org/10.1517/14656561003752730.

Redler, S., Dobson, K., Drichel, D., Heilmann, S., Wolf, S., Brockschmidt, F. F., ... & Betz, R. C. (2013). Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss. Journal of Dermatological science, 72(2), 186-188. https://doi.org/10.1016/j.jdermsci.2013.06.012.

Roy, R. K., Thakur, M., & Dixit, V. K. (2008). Hair growth promoting activity of Eclipta alba in male albino rats. Archives of Dermatological Research, 300(7), 357–364. https://doi.org/10.1007/s00403-008-0860-3.

Sadick, N. S., Callender, V. D., Kircik, L. H., & Kogan, S. (2017). New insight into the pathophysiology of hair loss trigger a paradigm shift in the treatment approach. J. Drugs Dermatol., 16(11), s135-s140.

Sharquie, K. E., & Al‐Obaidi, H. K. (2002). Onion juice (Allium cepa L.), a new topical treatment for alopecia areata. The Journal of dermatology, 29(6), 343-346. https://doi.org/10.1111/j.1346-8138.2002.tb00277.x.

Shimomura, Y., Agalliu, D., Vonica, A., Luria, V., Wajid, M., Baumer, A., ... & Christiano, A. M. (2010). APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex. Nature, 464 (7291), 043-1047. https://doi.org/10.1038/nature08875.

Sinclair, R. (1998). Fortnightly review: Male pattern androgenetic alopecia. BMJ, 317(7162), 865–869. https://doi.org/10.1136/bmj.317.7162.865.

Singh, K., Saeed, F., Ahmad, Z., Ahsan, F., & Shakya, P. (2016). Alopecia: introduction and overview of herbal treatment. Journal of Chemical and Pharmaceutical Research, 8(8), 59-64.

Stough, D., Stenn, K., Haber, R., Parsley, W. M., Vogel, J. E., Whiting, D. A., & Washenik, K. (2005). Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clinic Proceedings, 80(10), 1316–1322. https://doi.org/10.4065/80.10.1316.

Strazzulla, L. C., Wang, E. H. C., Avila, L., Sicco, K. L., Brinster, N., Christiano, A. M., & Shapiro, J. (2018). Alopecia areata: an appraisal of new treatment approaches and overview of current therapies. Journal of the American Academy of Dermatology, 78(1), 15-24. https://doi.org/10.1016/j.jaad.2017.04.1142.

Thorat, R. M., Jadhav, V. M., & Kadam, V. J. (2009). Development and evaluation of polyherbal formulations for hair growth-promoting activity. In.t J. Pharm. Tech. Res., 1(4), 1251-1254.

Valente Duarte de Sousa, I. C., & Tosti, A. (2013). New investigational drugs for androgenetic alopecia. Expert Opinion on Investigational Drugs, 22(5), 573-589. https://doi.org/10.1517/13543784.2013.784743.

Van Zuuren, E. J., Fedorowicz, Z., & Carter, B. (2012). Evidence‐based treatments for female pattern hair loss: a summary of a Cochrane systematic review. British Journal of Dermatology, 167(5), 995-1010. https://doi.org/10.1111/j.1365-2133.2012.11166.x.

Varothai, S., & Bergfeld, W. F. (2014). Androgenetic alopecia: An evidence-based treatment update. American Journal of Clinical Dermatology, 15(3), 217–230. https://doi.org/10.1007/s40257-014-0077-5.

Wang, L., Siegenthaler, J. A., Dowell, R. D., & Yi, R. (2016). Foxc1 reinforces quiescence in self-renewing hair follicle stem cells. Science, 351(6273), 613–617. https://doi.org/10.1126/science.aad5440.

Whiting, D. A. (1998). Male pattern hair loss: Current understanding. International Journal of Dermatology, 37(8), 561–566. https://doi.org/10.1046/j.1365-4362.1998.00542.x.

Wipf, A., Boysen, N., Hordinsky, M. K., Dando, E. E., Sadick, N., & Farah, R. S. (2019). The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future. Journal of Cosmetic and Laser Therapy, 21(5), 247-254. https://doi.org/10.1080/14764172.2018.1525743.

Zhang, J., Fu, S., Liu, S., Mao, T., & Xiu, R. (2000). The therapeutic effect of Ginkgo biloba extract in SHR rats and its possible mechanisms based on cerebral microvascular flow and vasomotion. Clinical Hemorheology and Microcirculation, 23(2,3,4), 133-138.

Baldness: Comprehensive aspects and its reassuring remedies

Abstract

References

Most read articles by the same author(s)